These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21960323)

  • 21. International Normalized Ratio Variability: A Measure of Anticoagulation Quality or a Powerful Mortality Predictor.
    Vanerio G
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2223-8. PubMed ID: 26232891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.
    MacCallum PK; Brennan PJ; Meade TW
    Arch Intern Med; 2000 Sep; 160(16):2462-8. PubMed ID: 10979057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosing practices of physicians for anticoagulation with warfarin during inpatient rehabilitation.
    Schaufele MK; Marciello MA; Burke DT
    Am J Phys Med Rehabil; 2000; 79(1):69-74; quiz 75-6. PubMed ID: 10678606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study.
    Chitsike RS; Rodger MA; Kovacs MJ; Betancourt MT; Wells PS; Anderson DR; Chagnon I; LE Gal G; Solymoss S; Crowther MA; Perrier A; White RH; Vickars LM; Ramsay T; Kahn SR
    J Thromb Haemost; 2012 Oct; 10(10):2039-44. PubMed ID: 22846068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
    Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
    J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.
    Banet GA; Waterman AD; Milligan PE; Gatchel SK; Gage BF
    Chest; 2003 Feb; 123(2):499-503. PubMed ID: 12576372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of the Alfalfa App in Warfarin Therapy Management for Patients Undergoing Venous Thrombosis Prevention and Treatment: Cohort Study.
    Cao H; Jiang S; Lv M; Wu T; Chen W; Zhang J
    JMIR Mhealth Uhealth; 2021 Mar; 9(3):e23332. PubMed ID: 33650976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
    Hylek EM; Chang YC; Skates SJ; Hughes RA; Singer DE
    Arch Intern Med; 2000 Jun; 160(11):1612-7. PubMed ID: 10847254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribers' behavior following below- versus above-range international normalized ratio values in warfarin-treated deep vein thrombosis patients.
    Raut MK; Nelson WW; Wang SW; Coleman CI; Lu L; Patel D; Schein JR; Xiang J; Damaraju CV
    Curr Med Res Opin; 2016 Jul; 32(7):1213-5. PubMed ID: 26960249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.
    Barta AL; Nutescu EA; Thompson PA; Bussey HI; Gulseth MP
    Am J Health Syst Pharm; 2015 Jul; 72(14):1188-94. PubMed ID: 26150568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended International Normalized Ratio testing intervals for warfarin-treated patients.
    Barnes GD; Kong X; Cole D; Haymart B; Kline-Rogers E; Almany S; Dahu M; Ekola M; Kaatz S; Kozlowski J; Froehlich JB
    J Thromb Haemost; 2018 Jul; 16(7):1307-1312. PubMed ID: 29763979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial.
    Dowd MB; Vavra KA; Witt DM; Delate T; Martinez K
    J Thromb Thrombolysis; 2011 May; 31(4):472-7. PubMed ID: 21161329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of subtherapeutic anticoagulation in the United States.
    Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
    Ageno W; Turpie AG; Steidl L; Ambrosini F; Cattaneo R; Codari RL; Nardo B; Venco A
    Am J Cardiol; 2001 Jul; 88(1):40-4. PubMed ID: 11423056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonadherence with INR monitoring and anticoagulant complications.
    Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
    Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.